Please Wait...

Upcoming Webinar: Removing Risk from Clinical Trial Management System (CTMS) Implementations

Removing Risk from Clinical Trial Management System (CTMS) Implementations

Join us for our upcoming webinar on November 28th during which Justin Hunt, Director of CTMS Implementation Services at Bioclinica, Inc., will present and discuss a case study providing insight into the benefits realized by a contract research organization (CRO) purchasing a CTMS who started with a small, limited implementation.

Enterprise CTMS systems require a significant investment of capital and manpower that extends beyond the challenges of the implementation process itself. The purchase of a CTMS therefore presents a certain element of risk because of the level of required resources. The common risks and challenges of implementing a CTMS can be mitigated by starting with a small, limited implementation and scaling the implementation as needed.

The webinar will enable you to:

  • Understand the benefits of directly matching the financial investment to the initial need, limiting your commitment until the requirements are met
  • Complete CTMS implementation in a matter of weeks, not months
  • Understand how to use an out-of-the-box, best-practices configuration capable of meeting both current and future needs

To join us for this webinar and learn more, register here.

Category: 

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Great advice from our Dir. Cardiovascular Imaging on how to achieve top quality imaging acquisitions & assessments… https://t.co/P57970FrOf
bioclinica (18 hours ago)
RT @CenterWatch: #CWWeekly: The increasing trend of adopting digital health and #mhealth apps for patient care. Read more, https://t.co/wo9…
bioclinica (19 hours ago)
RT @CenterWatch: Examining the difference between #patient engagement & patient recruitment. Read more in #CWPulse by @AshleyTointon, https…
bioclinica (19 hours ago)
RT @CenterWatch: How can #socialmedia play a role in health disparities and #clinicaltrial patient recruitment? Read more in #CWPulse by @A…
bioclinica (19 hours ago)
RT @RAPSorg: What New @FDAcdrhIndustry Guidance is Coming in FY 2018: Alternative 510(k) Pathway and More | #Regulatory Recon https://t.co/…
bioclinica (19 hours ago)
RT @RAPSorg: .@US_FDA Finalizes Guidance on Promotional Drug Labeling and Ads | #Regulatory Focus https://t.co/2rmtTWajlf #FDA #pharma
bioclinica (19 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices